A Trial to Complare the Injection Site Pain Experience of Semaglutide 0.25 mg and Dulaglutide 0.75 mg Administered sc

This study in healthy men and women looks at the injection site experience of semaglutide and dulaglutide given subcutaneously (s.c., under the skin). Participants will receive 1 dose of semaglutide 0.25 mg and 1 dose of dulaglutide 0.75 mg on the same day. The 2 injections will be given at least 30 minutes apart, one in each side of the stomach. Participants will be in the clinic research center for 1 day. A follow-up phone call will take place between 4 and 5 weeks after the injections were given.

本研究针对健康男性及女性受试者，考察司美格鲁肽（semaglutide）与度拉糖肽（dulaglutide）皮下注射（s.c.，即皮下给药）的注射部位反应情况。受试者将于同一天接受0.25mg司美格鲁肽与0.75mg度拉糖肽各1剂。两次注射需间隔至少30分钟，分别于腹部两侧进行。受试者将在临床研究中心停留1天。注射完成后4至5周将开展一次随访电话沟通。